AbbVie

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

In the last 4 hours

AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender, buoyed by… FiercePharma20:24

Yesterday

United States Anesthesia Drugs Research Report 2025: A $3.67 Bn Market by 2033 with Competitive Analysis of Baxter,… GlobeNewswire (Press Release)09:21 21-Jan-25

In the last 7 days

Fierce Pharma Asia—AbbVie's $1B pact with Simcere; Takeda's launch map; Samsung Bio's growth… FiercePharma16:07 17-Jan-25

$6.8 Bn Glaucoma 68-Market Analysis and Sales Forecasts 2023-2033 Featuring Abbvie, Allergan, Alcon, Pfizer, Merck,… GlobeNewswire (Press Release)11:26 17-Jan-25

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson BioPharma Dive14:00 16-Jan-25

AbbVie maintains top TV ad spend spot with Skyrizi but sees Rinvoq fall behind J&J's Tremfya,… FiercePharma11:08 16-Jan-25

AbbVie's Quarterly Earnings Preview: What You Need to Know Barchart09:17 16-Jan-25

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio Zacks09:00 16-Jan-25

JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole Pharmaceutical Technology08:10 16-Jan-25

April 17th Options Now Available For AbbVie (ABBV) Nasdaq17:37 15-Jan-25

JPM25, Day 3: AbbVie, UCB, WuXi Biologics and more are set to present FiercePharma15:40 15-Jan-25

AbbVie and Simcere Zaiming link to develop trispecific antibody Pharmaceutical Technology15:13 15-Jan-25

AbbVie and Simcere to advance multiple myeloma candidate in partnership worth over $1bn PMLiVE12:50 15-Jan-25

Aggressive protection of Stelara may indicate J&J’s immunology strategy Pharmaceutical Technology11:09 15-Jan-25

In the last month

AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock? Zacks15:39 14-Jan-25

AbbVie Has Immense Cash Flow Potential Seeking Alpha11:24 14-Jan-25

Abbvie and Simcere enter a $1B T-cell engager deal BioWorld22:31 13-Jan-25

AbbVie partners with Simcere Pharma unit to develop myeloma drug ENDPOINTS16:53 13-Jan-25

Alzheimer's Drugs Market Report and Forecast 2024-2032, Competitive Analysis of F. Hoffmann-La Roche, Novartis, Merck… GlobeNewswire (Press Release)16:49 13-Jan-25

Ex-Dividend Reminder: Abbott Laboratories, AbbVie and Phillips Edison Nasdaq15:47 13-Jan-25

JPM25: AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager FierceBiotech15:32 13-Jan-25

Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion… Benzinga15:10 13-Jan-25

AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma AbbVie (Press Release)14:09 13-Jan-25

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody… PR Newswire (Press Release)14:09 13-Jan-25

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology Business Wire (Press Release)14:03 13-Jan-25

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program AbbVie (Press Release)13:38 13-Jan-25

AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug Investopedia18:00 10-Jan-25

AbbVie takes $3.5B hit after emraclidine's phase 2 flop in schizophrenia FierceBiotech16:22 10-Jan-25

AbbVie writes off $3.5B on Cerevel drug after Phase 2 failures ENDPOINTS16:21 10-Jan-25

AbbVie to Record $3.5 Billion Charge on Failed Cerevel Drug (1) Bloomberg Law15:28 10-Jan-25

AbbVie's Stock Is Unfairly Cheap Seeking Alpha15:59 9-Jan-25

J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutiérrez-Ramos as… PR Newswire (Press Release)14:16 9-Jan-25

AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference AbbVie (Press Release)13:06 9-Jan-25

AbbVie’s head of genomics research on the transformative power of AI The McKinsey Quarterly17:01 8-Jan-25

Double Whammy For ALS As AbbVie/Calico And Denali Drugs Fail Scrip Pharma Intelligence17:05 7-Jan-25

AbbVie exercises first $40 million option to advance Capsida-partnered CNS gene therapy FierceBiotech15:57 7-Jan-25

ALS drugs from Denali, Calico come up short, marking more failures for Healey trial BioPharma Dive14:55 7-Jan-25

CoolMonth is Back With Deals on CoolSculpting® Elite by Allergan Aesthetics AbbVie (Press Release)13:19 7-Jan-25

Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative… PR Newswire (Press Release)12:52 7-Jan-25

AbbVie (ABBV) Lowers 2024 Earnings Outlook on Acquisition Costs TipRanks11:36 7-Jan-25

Rival AbbVie and Denali prospects flunk phase 2/3 ALS tests, denting hopes for shared mechanism FierceBiotech11:32 7-Jan-25

AbbVie Cuts 2024 EPS Guidance to Include Acquisition Costs Zacks11:09 7-Jan-25

AbbVie cuts 2024 profit forecast on acquisition expenses Yahoo! US21:55 6-Jan-25

2 No-Brainer Dividend Stocks to Buy With $250 in 2025 The Motley Fool09:22 6-Jan-25

Semaglutides Market Research Report 2024-2028 & 2033 Featuring Major Players, Pfizer, Roche, Merck, AbbVie, and Sanofi GlobeNewswire (Press Release)09:13 6-Jan-25

AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year Simply Wall St21:30 3-Jan-25

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call PR Newswire (Press Release)13:05 3-Jan-25

The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Barchart09:02 3-Jan-25

Bioconjugation Market Global Forecast to 2029 with Danaher, Lonza, Thermo Fisher Scientific, Merck, AbbVie, WuXi… GlobeNewswire (Press Release)12:58 2-Jan-25

$2.5+ Bn Body Contouring Treatments Markets - Global Analysis and Forecasts to 2029 with AbbVie, Inmode), Bausch… GlobeNewswire (Press Release)12:28 2-Jan-25

Pharma company spends ₹1.91 crore on foreign travel of doctors, gets reprimanded The Hindu14:47 26-Dec-24

AbbVie Sues PTO to Extend Life of Venclexta Cancer Drug Patent Bloomberg Law19:24 24-Dec-24

Action likely against AbbVie executive who signed self-declaration The Business Standard15:03 24-Dec-24

First order under Centre’s updated UCPMP code, on Abbvie, sees divergent views The Hindu Business Line15:01 24-Dec-24

AbbVie Healthcare India rejects wrongdoing allegations by the Department of Pharmaceuticals The Times of India14:44 24-Dec-24

Apex Committee for Pharma Marketing Practices finds Abbvie in violation of ethics code The Hindu Business Line09:24 24-Dec-24

Pharma Dept reprimands AbbVie Healthcare for unethical marketing practices The Business Standard05:11 24-Dec-24

Brazil Medical Aesthetics Market Focused Insights 2024-2029: AbbVie, Bausch Health Companies,… Business Wire (Press Release)18:47 23-Dec-24

AbbVie Healthcare under government lens for 'violations' The Times of India18:24 23-Dec-24

Is AbbVie Stock a Buy? The Motley Fool13:30 23-Dec-24

view more headlines

22 Jan 20:24

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

AbbVie

AbbVie News

Biotech Top Stories

UK Top Stories

World Top Stories